Home > Insider Trading > Filing (0001140361-16-059153)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881524	Vivus Inc	VVUS	Pharmaceutical Preparations (2834)	943136179

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1557543	North Tide Capital, Llc	500 Boylston Street Suite 1860 Boston MA 02116	No	No	Yes	No
1594068	Conan Laughlin	500 Boylston Street Suite 1860 Boston MA 02116	No	No	Yes	No
1594882	North Tide Capital Master, Lp	500 Boylston Street Suite 1860 Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-24	15,500	$1.08	13,015,500	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2016-03-24	7,500	$1.10	13,023,000	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2016-03-24	2,000	$1.10	13,025,000	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2016-03-28	150,000	$1.13	13,175,000	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2016-03-28	27,000	$1.13	13,202,000	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Footnotes

Shares reported herein represent as of March 24, 2016, (i) 11,518,750 shares held by North Tide Capital Master, LP (the "Master Fund") and (ii) 1,506,250 shares held by a managed account (the "Account) and as of March 28, 2016, (i) 11,651,500 shares held by the Master Fund and (ii) 1,550,500 shares held by the Account. North Tide Capital, LLC ("North Tide") serves as investment manager for the Master Fund and the Account. Mr. Laughlin serves as manager of North Tide. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.